Chinese guidelines for diagnosis and treatment of multiple sclerosis(2023 edition)
Multiple sclerosis(MS)is an immune-mediated central nervous system inflammatory demyelinating disease.In the past 10 years,research in the fields of epidemiology pathology,disease activity,and progression has driven updates in clinical classification,diagnostic criteria,and treatment goals,providing more choices with new disease-modifying therapies.The Chinese Society of Neuroimmunology has proposed diagnostic,differential diagnostic,treatment principles,and specific recommendations for MS in China through querying and evaluating existing research evidence,referencing international consensus and guidelines,considering the national situation,and repeated discussions.
NETL
NSTL
万方数据
维普
